Exploiting the potential of the ubiquitin-proteasome system in overcoming tyrosine kinase inhibitor resistance in chronic myeloid leukemia
The advent of tyrosine kinase inhibitors (TKI) targeting BCR-ABL has drastically changed the treatment approach of chronic myeloid leukemia (CML), greatly prolonged the life of CML patients, and improved their prognosis. However, TKI resistance is still a major problem with CML patients, reducing th...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
KeAi Communications Co., Ltd.
2024-09-01
|
| Seri Bilgileri: | Genes and Diseases |
| Konular: | |
| Online Erişim: | http://www.sciencedirect.com/science/article/pii/S2352304223004336 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|